Surrozen, Inc. (SRZN) Stock Grade

About Surrozen, Inc.'s fundamentals

Surrozen is a biotechnology company with a market capitalization of $169.0 million that is currently unprofitable, having reported a net loss in its latest annual statement with a net margin of -6960.8%. The company experienced significant revenue contraction, declining 67.4% year-over-year, indicating substantial challenges in its commercial operations or product sales. With no dividend yield and an inability to generate positive earnings, the company does not have a meaningful P/E ratio. The elevated return on equity figure reflects accounting volatility rather than operational strength, given the company's loss-making status.